Pharmacology of cognition: a panacea for neuropsychiatric disease?

Sarah J Bailey; Joanna C Neill; Paula M Moran

doi:10.1111/bph.13956

Pharmacology of cognition: a panacea for neuropsychiatric disease?

Br J Pharmacol. 2017 Oct;174(19):3133-3135. doi: 10.1111/bph.13956.

Authors

Sarah J Bailey¹, Joanna C Neill², Paula M Moran³

Affiliations

¹ Drug and Target Discovery, Department of Pharmacy and Pharmacology, University of Bath, Bath, UK.
² Division of Pharmacy and Optometry, School of Health Sciences, Faculty of Medicine, Biology and Health, University of Manchester, Manchester, UK.
³ School of Psychology, University of Nottingham, Nottingham, UK.

Abstract

This article is part of a themed section on Pharmacology of Cognition: a Panacea for Neuropsychiatric Disease? To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v174.19/issuetoc.

Publication types

Editorial
Introductory Journal Article

MeSH terms

Animals
Cognition*
Humans
Mental Disorders / drug therapy*